Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individua
Authors:
Journal: American journal of preventive cardiology
Publication Type: Journal Article
Date: 2026
DOI: PMC13632017
ID: 42828238
Abstract
A coronary artery calcium (CAC) score of zero using the conventional Agatston scoring method (Agatston-1.0) is associated with very low cardiovascular risk (the "Power of Zero"); however, a small proportion of individuals with CAC=0 still develop coronary heart disease (CHD). Agatston-1.0 relies on thick slices (2.5-3 mm) and a fixed attenuation threshold (≥130 HU), which may miss early, small, low-density, or partially calcified coronary plaques. Agatston-2.0 is an artificial intelligence (AI) framework for automated coronary segmentation and continuous voxel-wise calcium quantification without fixed thresholds, applicable to CT scans with slice thickness ≥0.2 mm and generating an AI-derived CAC score (AI-CAC).
Reference List
- Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–832.|||Budoff M.J., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.P., Tseng P.H., et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49(18):1860–1870.|||Budoff M.J., Young R., Burke G., Jeffrey Carr J., Detrano R.C., Folsom A.R., et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) Eur Heart J. 2018;39(25):2401–2408.|||Blaha M.J., Whelton S.P., Al Rifai M., Dardari Z., Shaw L.J., Al-Mallah M.H., et al. Comparing risk scores in the prediction of coronary and cardiovascular deaths: coronary artery calcium consortium. JACC Cardiovasc Imaging. 2021;14(2):411–421.|||Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336–1345.|||Goff D.C., Jr., Lloyd-Jones D.M., Bennett G., Coady S., D'Agostino R.B., Sr., Gibbons R., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–2959.|||Grundy S.M., Stone N.J., Bailey A.L., Beam C., Birtcher K.K., Blumenthal R.S., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. J Am Coll Cardiol. 2019;73(24):3168–3209.|||Blumenthal R.S., Morris P.B., Gaudino M., Johnson H.M., Anderson T.S., Bittner V.A., et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026|||Naghavi M., Wong N.D., McConnell M.V., Maron D.J., Nasir K., Henschke C.I., et al. Coronary artery calcium (CAC) imaging as a diagnostic test: insurance coverage implications. JACC Cardiovasc Imaging. 2025|||Blaha M.J., Cainzos-Achirica M., Dardari Z., Blankstein R., Shaw L.J., Rozanski A., et al. All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium. Atherosclerosis. 2020;294:72–79.|||Blaha M., Budoff M.J., Shaw L.J., Khosa F., Rumberger J.A., Berman D., et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging. 2009;2(6):692–700.|||Nasir K., Bittencourt M.S., Blaha M.J., Blankstein R., Agatson A.S., Rivera J.J., et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol. 2015;66(15):1657–1668.|||Cainzos-Achirica M., Miedema M.D., McEvoy J.W., Al Rifai M., Greenland P., Dardari Z., et al. Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA study (Multi-Ethnic Study of Atherosclerosis) Circulation. 2020;141(19):1541–1553.|||Blaha M.J., Cainzos-Achirica M., Greenland P., McEvoy J.W., Blankstein R., Budoff M.J., et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA) Circulation. 2016;133(9):849–858.|||Shea S., Navas-Acien A., Shimbo D., Brown E.R., Budoff M., Bancks M.P., et al. Spatially weighted coronary artery calcium score and coronary heart disease events in the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2021;14(1)|||Budoff M.J., McClelland R.L., Nasir K., Greenland P., Kronmal R.A., Kondos G.T., et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J. 2009;158(4):554–561.|||Joshi P.H., Blaha M.J., Budoff M.J., Miedema M.D., McClelland R.L., Lima J.A., et al. The 10-year prognostic value of zero and minimal CAC. JACC: Cardiovasc Imaging. 2017;10(8):957–958.|||Han D., Klein E., Friedman J., Gransar H., Achenbach S., MH Al-Mallah, et al. Prognostic significance of subtle coronary calcification in patients with zero coronary artery calcium score: from the CONFIRM registry. Atherosclerosis. 2020;309:33–38.|||Willemink M.J., van der Werf N.R., Nieman K., Greuter M.J.W., Koweek L.M., Fleischmann D. Coronary artery calcium: A technical argument for a new scoring method. J Cardiovasc Comput Tomogr. 2019;13(6):347–352.|||Urabe Y., Yamamoto H., Kitagawa T., Utsunomiya H., Tsushima H., Tatsugami F., et al. Identifying small coronary calcification in non-contrast 0.5-mm slice reconstruction to diagnose coronary artery disease in patients with a conventional zero coronary artery calcium score. J Atheroscler Thromb. 2016;23(12):1324–1333.|||Rutten A., Isgum I., Prokop M. Coronary calcification: effect of small variation of scan starting position on Agatston, volume, and mass scores. Radiology. 2008;246(1):90–98.|||van der Werf N.R., Willemink M.J., Willems T.P., Greuter M.J.W., Leiner T. Influence of dose reduction and iterative reconstruction on CT calcium scores: a multi-manufacturer dynamic phantom study. Int J Cardiovasc Imaging. 2017;33(6):899–914.|||Liang C.J., Budoff M.J., Kaufman J.D., Kronmal R.A., Brown ER. An alternative method for quantifying coronary artery calcification: the multi-ethnic study of atherosclerosis (MESA) BMC Med Imaging. 2012;12:14.|||Tzolos E., Han D., Klein E., Friedman J.D., Hayes S.W., Thomson L.E.J., et al. Detection of small coronary calcifications in patients with Agatston coronary artery calcium score of zero. J Cardiovasc Comput Tomogr. 2022;16(2):150–154.|||van der Bijl N., de Bruin P.W., Geleijns J., Bax J.J., Schuijf J.D., de Roos A., et al. Assessment of coronary artery calcium by using volumetric 320-row multi-detector computed tomography: comparison of 0.5 mm with 3.0 mm slice reconstructions. Int J Cardiovasc Imaging. 2010;26(4):473–482.|||Raggi P., Callister T.Q., Cooil B. Calcium scoring of the coronary artery by electron beam CT: how to apply an individual attenuation threshold. AJR Am J Roentgenol. 2002;178(2):497–502.|||Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979;110(3):281–290.|||Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871–881.|||Feinleib M., Kannel W.B., Garrison R.J., McNamara P.M., Castelli WP. The Framingham offspring study. Design and preliminary data. Prev Med. 1975;4(4):518–525.|||Splansky G.L., Corey D., Yang Q., Atwood L.D., Cupples L.A., Benjamin E.J., et al. The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165(11):1328–1335.|||Carr J.J., Nelson J.C., Wong N.D., McNitt-Gray M., Arad Y., Jacobs D.R., Jr, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and coronary artery risk Development in Young adults (CARDIA) study. Radiology. 2005;234(1):35–43.|||Araki T., Nishino M., Gao W., Dupuis J., Washko G.R., Hunninghake G.M., et al. Anterior mediastinal masses in the Framingham Heart Study: prevalence and CT image characteristics. Eur J Radiol Open. 2015;2:26–31.|||Blaha M.J., Mortensen M.B., Kianoush S., Tota-Maharaj R., Cainzos-Achirica M. Coronary artery calcium scoring: is it time for a change in methodology? JACC Cardiovasc Imaging. 2017;10(8):923–937.|||Blaha M.J., Dzaye O. Subthreshold coronary artery calcium - redefining the coronary artery calcium score of zero? J Cardiovasc Comput Tomogr. 2022;16(2):155–157.|||Tamis-Holland J.E., Jneid H., Reynolds H.R., Agewall S., Brilakis E.S., Brown T.M., et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891–e908.|||Matsuura Y., Kanter J.E., Bornfeldt KE. Highlighting residual atherosclerotic cardiovascular disease risk. Arter Thromb Vasc Biol. 2019;39(1):e1–e9.|||Yildiz M., Ashokprabhu N., Shewale A., Pico M., Henry T.D., Quesada O. Myocardial infarction with non-obstructive coronary arteries (MINOCA) Front Cardiovasc Med. 2022 Volume 9 - 2022.|||Pasupathy S., Air T., Dreyer R.P., Tavella R., Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131(10):861–870.|||Parlati A.L.M., Nardi E., Sucato V., Madaudo C., Leo G., Rajah T., et al. ANOCA, INOCA, MINOCA: the new frontier of coronary syndromes. J Cardiovasc Dev Dis. 2025;12(2):64.|||Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient. Circulation. 2003;108(14):1664–1672.|||Naghavi M., Falk E., Hecht H.S., Jamieson M.J., Kaul S., Berman D., et al. From vulnerable plaque to vulnerable patient—Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98(2):2–15.|||Tomaniak M., Katagiri Y., Modolo R., de Silva R., Khamis R.Y., Bourantas C.V., et al. Vulnerable plaques and patients: state-of-the-art. Eur Heart J. 2020;41(31):2997–3004.|||Schulze K., Biavati F., Föllmer B., Tsogias S., Chimed S., Balogh H., et al. Detection of calcified plaques: comparison between coronary CT angiography and thin-slice non-contrast CT with deep learning-aided image registration. Eur Radiol. 2026|||Christensen J.L., Sharma E., Gorvitovskaia A.Y., Watts J.P., Jr, Assali M., Neverson J., et al. Impact of slice thickness on the predictive value of lung cancer screening computed tomography in the evaluation of coronary artery calcification. J Am Heart Assoc. 2019;8(1)|||Kim S.Y., Suh Y.J., Lee H-J, Kim YJ. Prognostic value of coronary artery calcium scores from 1.5 mm slice reconstructions of electrocardiogram-gated computed tomography scans in asymptomatic individuals. Sci Rep. 2022;12(1)|||Sandhu A.T., Rodriguez F., Ngo S., Patel B.N., Mastrodicasa D., Eng D., et al. Incidental coronary artery calcium: opportunistic screening of previous nongated chest computed tomography scans to improve statin rates (NOTIFY-1 Project) Circulation. 2023;147(9):703–714.